Back to results
US 2024/0197836 A1Published application
Method of treating diabetes type 2 by administering ultrarapid acting insulin
AssigneeMannKind Corporation
InventorsPeter Richardson, Robert A. Baughman, Elizabeth Potocka, Anders Hasager Boss, Richard Petrucci
Life of this patent
Estimating the term…
Abstract
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Claims15
A method of improving post-prandial blood glucose homeostasis in an overweight patient with type 2 diabetes currently being treated with a suppressor of hepatic glucose output, said method comprising:
- administering an ultrarapid acting insulin (URAI) preparation with at least one established meal;
- wherein said treatment results in weight loss or reduced weight gain as compared to treatment with a suppressor of hepatic glucose output alone.
Dependencies are inferred from the claim text.